COGENT BIOSCIENCES ANNOUNCES PROPOSED $150 MILLION PUBLIC OFFERING OF COMMON STOCK
COGENT BIOSCIENCES INC - PROCEEDS TO FUND BEZUCLASTINIB DEVELOPMENT AND COMMERCIAL ACTIVITIES
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.